The stock climbed 8.47 per cent to settle at Rs 1,060.45 on the BSE after climbing as much as 16.46 per cent to Rs 1,138.60, a 52-week high.
On the National Stock Exchange, the stock rose 8.55 per cent to close at Rs 1,060.
Ajanta Pharma said today profit more than doubled to Rs 70.09 crore in the three months ended March 31, primarily on the back of robust sales in the domestic market. The company had reported a profit of Rs 27.09 crore a year earlier.
For the year ended March 31, the company posted a consolidated net profit of Rs 233.88 crore, an over two-fold increase from Rs 112.11 crore in 2012-13. Net sales rose to Rs 1,178.29 crore in the previous financial year from Rs 920.14 crore.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
